NeuroGeneces

NeuroGeneces is a Consumer Electronics and Health Care startup, based in the United States, founded in 2016. The company's slogan "Transforming cognitive performance while you sleep" emphasizes its focus on leveraging sleep science and neuroscience to enhance cognitive abilities. NeuroGeneces' flagship product, NeuroInsight™, aims to detect atypical brain decline up to two decades before symptoms emerge, allowing for early intervention. NeuroInsight™ utilizes advanced neuroscience and sleep science to inspire behavioral and lifestyle changes, addressing brain health proactively. By identifying issues at an early stage, the platform intends to enable meaningful impacts through timely interventions. The company's dedication to detecting problems before they become symptomatic aligns with an increasing global emphasis on preventive healthcare measures. Notably, the startup received Non Equity Assistance investment from VentureWell on 10th November 2023. This investment indicates the recognition and support from a reputable investor in the field. With trials underway, NeuroGeneces appears poised to make an impact in the health tech sector, making it a compelling prospect for VentureCapital consideration.